Table 2 Lesion characteristics
| Â | pre propensity-matched analysis | post propensity-matched analysis | |||||
|---|---|---|---|---|---|---|---|
M-BSKT | PS | PÂ Value | M-BSKT | PS | P Value | ||
n = 40 | n = 80 | n = 34 | n = 34 | ||||
Location | LAD-D1 | 27 (67.5%) | 56 (70.0%) | 0.481 | 26 (76.5%) | 24 (70.6%) | 0.741 |
LAD-LCX | 7 (17.5%) | 13 (16.3%) | 6 (17.6%) | 8 (23.5%) | |||
LCX-OM | 2 (5.0%) | 7 (8.8%) | 2 (5.9%) | 1 (2.9%) | |||
LAD-RI | 3 (7.5%) | 1 (1.3%) | 0 | 1 (2.9%) | |||
RCA-PD | 1 (2.5%) | 3 (3.8%) | 0 | 0 | |||
Medina | 1.1.1 | 31 (77.5%) | 63 (78.8%) | 1 | 26 (76,5%) | 25 (73.5%) | 0.846 |
1.0.1 | 5 (12.5%) | 9 (11.25%) | 4 (11.8%) | 6 (17.6%) | |||
0.1.1 | 4 (10.0%) | 8 (10.0%) | 4 (11.8%) | 3 (8.8%) | |||